Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
12 July 2023Website:
http://60degreespharma.comNext earnings report:
N/ALast dividends:
N/ANext dividends:
N/APrice
after hours | Wed, 03 Jul 2024 19:51:14 GMTDividend
Analysts recommendations
Institutional Ownership
SXTP Latest News
60 Degrees Pharma Presents Review of Safety, Efficacy Data of 8-Aminoquinolines for Malaria and Babesiosis Treatment at ILADS Annual Scientific Meeting
WASHINGTON, Sept. 06, 2023 (GLOBE NEWSWIRE) -- 60 Degrees Pharmaceuticals Inc. (“60P” or the “Company”) (Nasdaq: SXTP ), a pharmaceutical company focused on developing new medicines for infectious diseases, announced today that CEO Dr. Geoff Dow and CFO Ty Miller will participate in the H.C. Wainwright 25th Annual Global Investment Conference September 11-13, to be held in New York City.
60 Degrees Pharmaceuticals (NASDAQ: SXTP ) stock is on the rise Thursday following the company's public debut yesterday. The public launch of SXTP stock saw the company offering up 1,415,095 units at a price of $5.30 each.
What type of business is 60 Degrees Pharmaceuticals?
60 Degrees Pharmaceuticals, Inc. operates as a specialty pharmaceutical company that engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases. The company offers Arakoda for malaria preventative treatment. It also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19; Tafenoquine for fungal lung infections, tick-borne diseases, candidiasis, and other infectious and non-infectious diseases; and Celgosivir for respiratory viruses and dengue. The company was founded in 2010 and is based in Washington, District of Columbia.
What sector is 60 Degrees Pharmaceuticals in?
60 Degrees Pharmaceuticals is in the Healthcare sector
What industry is 60 Degrees Pharmaceuticals in?
60 Degrees Pharmaceuticals is in the Biotechnology industry
What country is 60 Degrees Pharmaceuticals from?
60 Degrees Pharmaceuticals is headquartered in United States
When did 60 Degrees Pharmaceuticals go public?
60 Degrees Pharmaceuticals initial public offering (IPO) was on 12 July 2023
What is 60 Degrees Pharmaceuticals website?
https://60degreespharma.com
Is 60 Degrees Pharmaceuticals in the S&P 500?
No, 60 Degrees Pharmaceuticals is not included in the S&P 500 index
Is 60 Degrees Pharmaceuticals in the NASDAQ 100?
No, 60 Degrees Pharmaceuticals is not included in the NASDAQ 100 index
Is 60 Degrees Pharmaceuticals in the Dow Jones?
No, 60 Degrees Pharmaceuticals is not included in the Dow Jones index
When does 60 Degrees Pharmaceuticals report earnings?
Next earnings report date is not announced yet